![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product c... Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). Show more
Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target Prothena will...
Net cash used in operating and investing activities was $73.2 million in the first quarter of 2024; quarter-end cash and restricted cash position was $548.7 million Advanced potential...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.86 | 3.63175675676 | 23.68 | 25.42 | 23.041 | 385187 | 24.27989182 | CS |
4 | 3.99 | 19.4160583942 | 20.55 | 25.42 | 19.55 | 446224 | 22.4888208 | CS |
12 | 1.55 | 6.74206176599 | 22.99 | 25.42 | 18.69 | 515465 | 21.67114885 | CS |
26 | -7.89 | -24.3293246994 | 32.43 | 33.84 | 18.69 | 587605 | 24.24747948 | CS |
52 | -39.5 | -61.6801998751 | 64.04 | 70.09 | 18.69 | 642237 | 33.98311397 | CS |
156 | -28.09 | -53.372601178 | 52.63 | 79.749 | 18.69 | 529375 | 43.64325687 | CS |
260 | 14.78 | 151.43442623 | 9.76 | 79.749 | 6.44 | 438774 | 36.94028535 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions